<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=314834185700910&amp;ev=PageView&amp;noscript=1">

New Update: Healthcare Costs Increasing by Over 60% in Some States. Will you be impacted?

Learn More

3 Surprising Investing Ideas for Catalent Employees in 2025

image-table

Healthcare Provider Update: Healthcare Provider for Catalent Catalent, a prominent player in the biopharmaceutical industry, collaborates with various healthcare providers to optimize its services. One of the notable healthcare partners for Catalent is UnitedHealthcare, which often works with organizations like Catalent to ensure streamlined processes in drug delivery and related healthcare services. Potential Healthcare Cost Increases in 2026 In 2026, healthcare costs are expected to rise significantly, primarily driven by looming federal policies and medical inflation. Reports indicate that Affordable Care Act (ACA) premiums may surge due to the potential expiration of enhanced premium subsidies, causing many policyholders to face out-of-pocket increases of over 75%. Insurers are already proposing steep rate hikes, with some states expected to see increases as high as 66%. This combination of factors, including rising healthcare service costs and more aggressive premium strategies from insurers, is set to intensify financial pressures on consumers in the coming year. Click here to learn more

'For Catalent employees, the rapid market rebound in 2025 reinforces the value of disciplined, research-driven decision-making—especially when considering sector trends like tech's recovery and the structural challenges in consumer staples.” – Michael Corgiat, a representative of The Retirement Group, a division of Wealth Enhancement.

'The 2025 market turnaround highlights how Catalent employees can benefit from focusing on long-term sector dynamics—such as technology’s renewed potential—rather than reacting to short-term volatility.” – Brent Wolf, a representative of The Retirement Group, a division of Wealth Enhancement.

In this article we will discuss:

  1. How the rebound in U.S. equities may still offer opportunities for long-term investors.

  2. Why technology stocks are regaining momentum following a valuation reset.

  3. The structural challenges facing consumer staples despite their traditional defensive appeal.

The first seven months of 2025 showcased how difficult it can be to time investment decisions during a year of sharp economic pivots and sudden market reversals. Early in the year, global tariff announcements sent shockwaves through markets, causing the S&P 500® to fall 19% from its mid-February highs, 1  narrowly sidestepping bear market territory. But recovery followed quickly. The index rebounded roughly 30% from its April 8 low. 2  For Catalent employees with exposure to equity markets, this swift rebound highlights the challenge of reacting to short-term volatility instead of maintaining a long-term perspective.

While trade-related uncertainty remains, a broader question has emerged: Has the rebound outpaced fundamental growth? Some analysts believe market valuations are stretched, while others—such as Fidelity’s Denise Chisholm—suggest that specific sectors, particularly technology, still present potential opportunities. Chisholm, Fidelity’s Director of Quantitative Market Strategy, points to three investing themes that could help Catalent retirees and employees make more informed decisions as the year continues. 3

1. U.S. Stocks Could Keep Outperforming

Following the April rally, many began scrutinizing market valuations. Despite concerns that stocks were overvalued before the downturn and may be even more so now, Chisholm’s historical analysis of 19%+ declines shows limited connection between elevated valuations during pullbacks and future performance. This insight may be particularly useful for Catalent employees with retirement accounts invested in broad-market indexes.

A more revealing factor is corporate earnings expectations. “Net earnings revisions”—the difference between upward and downward analyst estimates—fell into the bottom 25% of their historical range in April. 4  Historically, this has been followed by an average 12% S&P 500 gain over the next 12 months, according to Haver Analytics and Fidelity data from 1977 through May 2025. 4

Another encouraging sign is the increase in real personal income earlier this year. For those at Catalent planning their post-career financial strategies, rising consumer income tends to support stronger corporate earnings. In fact, when real personal income rises, corporate earnings growth over the following year is similarly positive 85% of the time. 4

Credit markets offer another signal. The narrow spread between high-yield corporate bonds and U.S. Treasuries—often viewed as a proxy for investor sentiment—suggests continued optimism. For Catalent stakeholders tracking market health, this may reflect investor confidence in corporate profitability and credit conditions.

2. Technology Stocks May Take the Lead Again

Tech stocks experienced a correction in early 2025 after years of strong performance. This adjustment pushed their valuations—based on the forward price-to-earnings ratio relative to the broader S&P 500—into the historical median range. Historically, when this level is reached, tech stocks have outperformed the S&P 500 by 5% over the following 12 months. 4

For Catalent professionals considering sector allocation, this valuation reset may indicate an opening in technology. According to research from Fidelity and FactSet, when speculative tech names—typically viewed as high-risk—drop into the lowest 25% of historical valuations, the entire tech sector has a 79% chance of outperforming the broader market over the following year. 4

This combination of historical probability and relative value makes the tech sector worth close attention. The reset in prices could renew investor interest, especially if upcoming earnings results outperform expectations. Catalent employees managing portfolios may discover longer-term growth potential in parts of the market that have experienced recalibrated valuations.

3. The Underperformance of Consumer Staples

Consumer staples—companies producing essentials like food and household items—are often considered more stable holdings. During the early 2025 market dip, many investors shifted toward these stocks in search of consistency. However, Catalent retirees evaluating income-focused portfolios may want to reassess the sector’s outlook.

Although valuations have returned to historical medians, consumer staples have not historically outperformed unless valuations reach the lower quartile. Data since 2000 show weak performance from mid-range valuation levels, especially compared to the tech sector’s behavior.

In addition, profit margins in the sector have steadily declined. By early 2025, margins were near two-decade lows, which may limit earnings growth. For Catalent employees reviewing income strategies in retirement, these long-term pressures may reduce the appeal of the sector—even if consumer demand remains relatively consistent during downturns.

A Prospective View for Catalent Employee Portfolios

After a dramatic rebound in 2025, many investors are weighing their next steps. For Catalent employees balancing growth potential and downside exposure, historical trends may offer useful insights. The mid-range valuations in technology, rising real income, and contrarian earnings signals suggest that U.S. equities may still provide room for further advancement.

Sector allocation decisions may play an increasingly important role. Technology could benefit from valuation resets and performance trends, while consumer staples may face continued margin pressure. Catalent retirees exploring future-focused allocations may want to pay attention to these sector-specific developments.

Chisholm’s findings offer a research-based perspective to assess these shifts. She emphasizes evaluating valuation resets, earnings expectations, and credit spreads rather than reacting to market headlines. For Catalent stakeholders, this measured approach may offer a clearer path through ongoing market uncertainty.

In June 2025, J.P. Morgan Asset Management highlighted dividend-paying stocks—particularly in health care and utilities—as appealing options during late-cycle environments due to their consistent cash flow. 5  They also noted that infrastructure investments may help offset inflation risks, and that short-duration bonds yielding over 5% can provide income while limiting interest rate sensitivity. These three ideas—dividends, infrastructure, and short-term bonds—may contribute to a more balanced approach for Catalent retiree portfolios.

Key Takeaway for Catalent Employees

Explore the major investment themes of 2025: U.S. stock momentum, shifting tech valuations, and structural concerns in consumer staples. Learn how trends in net earnings revisions, bond spreads, and income growth can inform longer-term planning. Historical data from Haver Analytics, FactSet, and Bloomberg, along with Chisholm’s sector analysis, may provide meaningful context for Catalent employees navigating today’s complex market environment.

Analogy:

Today’s investment environment for Catalent employees is like planning a well-balanced retirement meal: short-duration bonds are the refreshing drink—low volatility and steady; infrastructure funds are the hearty side—resilient in tough economic climates; and dividend stocks serve as the main course—reliable and consistent. Like a nourishing plate, each component plays a distinct role in adjusting to evolving market conditions.

Featured Video

Articles you may find interesting:

Loading...

Sources:

1. Yahoo!Finance. ' Analyst resets S&P 500 forecast for rest of 2025 ,' by Todd Campbell, 20 July 2025. 

2. Quoniam. ' Market commentary equities: Low single-digit returns in 2025, but massive undercurrents ,' by Mark Frielinghaus, 10 July 2025. 

3. Fidelity. ' 4 investing ideas for the rest of 2025 ,' by Denise Chisolm, 4 June 2025. 

4. Fidelity. ' Q3 2025 Quarterly Sector and Investment Research Update ,' by Denise Chisolm, 28 July 2025. 

5. J.P. Morgan Asset Management. ' Mid-Year Investment Outlook 2025: Comfortably Uncomfortable ,' by J.P. Morgan Chase & Co., 5 May 2025.

What is the Catalent 401(k) Savings Plan?

The Catalent 401(k) Savings Plan is a retirement savings plan that allows employees to save for their future by contributing a portion of their salary on a pre-tax or Roth after-tax basis.

How can I enroll in the Catalent 401(k) Savings Plan?

Employees can enroll in the Catalent 401(k) Savings Plan by accessing the benefits portal or contacting Human Resources for guidance on the enrollment process.

What are the eligibility requirements for the Catalent 401(k) Savings Plan?

To be eligible for the Catalent 401(k) Savings Plan, employees typically need to be at least 21 years old and have completed a specified period of service with the company.

Does Catalent offer a company match for the 401(k) Savings Plan?

Yes, Catalent offers a company match for contributions made to the 401(k) Savings Plan, which helps employees maximize their retirement savings.

How much can I contribute to the Catalent 401(k) Savings Plan?

Employees can contribute up to the IRS annual limit to the Catalent 401(k) Savings Plan, which may vary each year. It’s important to check the current limits.

When can I start making contributions to the Catalent 401(k) Savings Plan?

Employees can start making contributions to the Catalent 401(k) Savings Plan after they complete the eligibility requirements and enroll in the plan.

Can I change my contribution amount in the Catalent 401(k) Savings Plan?

Yes, employees can change their contribution amount at any time during the year by accessing the benefits portal or contacting Human Resources.

What investment options are available in the Catalent 401(k) Savings Plan?

The Catalent 401(k) Savings Plan offers a variety of investment options, including mutual funds and target-date funds, allowing employees to choose based on their risk tolerance and retirement goals.

How often can I change my investment allocations in the Catalent 401(k) Savings Plan?

Employees can change their investment allocations in the Catalent 401(k) Savings Plan at any time, subject to the plan's trading restrictions.

What happens to my Catalent 401(k) Savings Plan if I leave the company?

If you leave Catalent, you have several options for your 401(k) Savings Plan, including rolling it over to another qualified plan, cashing it out, or leaving it in the Catalent plan if permitted.

With the current political climate we are in it is important to keep up with current news and remain knowledgeable about your benefits.
Catalent's Pension Plan: Catalent offers a comprehensive retirement benefits package designed to support its employees' financial wellness. The primary pension plan provided by Catalent is known as the "Catalent Pension Plan." This plan includes a defined benefit formula based on an employee’s years of service and final average pay. Typically, to qualify for the pension plan, employees must have a minimum of five years of service and be at least 55 years of age. The specific pension formula details and eligibility criteria are laid out in the employee benefits documentation provided internally by Catalent​ (Catalent)​ (Catalent Investor Relations)​ (FiercePharma). Catalent's 401(k) Plan: Catalent also offers a 401(k) plan to its employees, which is referred to as the "Catalent 401(k) Savings Plan." Employees are eligible to participate in the 401(k) plan from their first day of employment. The company provides a generous matching contribution, where Catalent matches 50% of the first 6% of the employee's contributions. This plan is designed to help employees save for retirement with the added benefit of tax deferral on contributions and earnings​
Catalent has been undergoing significant restructuring since 2023, including multiple rounds of layoffs affecting various facilities. In late 2023, the company laid off approximately 300 employees as part of a cost-cutting initiative aimed at consolidating its facilities. This was followed by further layoffs in early 2024, including the reduction of 130 staff members at its Bloomington, Indiana site, which is being sold to Novo Nordisk as part of a broader $16.5 billion acquisition deal expected to close by the end of 2024. The restructuring is driven by reduced demand for COVID-19-related services and a need to increase efficiency and reduce costs across its operations. Importance: Addressing this news is crucial due to the current economic environment, where companies are navigating the aftermath of the pandemic, fluctuating demand, and economic pressures. These changes also reflect broader trends in the biopharma industry, where consolidation and cost-cutting measures are common as companies adjust to new market realities​
Stock Options: Catalent offers stock options to its employees as part of its long-term incentive plan. These options are designed to align the interests of employees with those of shareholders. Employees receive the right to purchase company stock at a predetermined price, known as the exercise price, after a specified vesting period. Restricted Stock Units (RSUs): Catalent also provides RSUs to its employees, which represent a promise to deliver shares of the company's stock in the future. RSUs typically vest over a period of time, encouraging employees to remain with the company. Once vested, the RSUs are converted into shares, which the employee can then sell or hold.
Catalent offers a comprehensive suite of health benefits to its employees, designed to meet diverse needs and foster a healthy lifestyle. Their health insurance plans cover a wide range of medical services, emphasizing both personal and financial wellness. Employees have access to wellness programs, which aim to manage healthcare costs and encourage a healthy lifestyle. These programs include health insurance, wellness incentives, and various support resources to balance work and personal life, such as generous paid time off and flexible work arrangements. In 2022, 2023, and 2024, Catalent continued to enhance its benefits offerings, aligning them with industry standards and employee needs. Recent updates include tuition reimbursement, global scholarship programs for employees' children, and comprehensive retirement plans. The company has also been recognized for its commitment to diversity and inclusion, receiving accolades as a “Best Place to Work for People with Disabilities” for consecutive years. Specific healthcare-related terms and acronyms frequently used by Catalent include "OptiDose® Design Solution," "RP Scherer Softgel Technology," and "OneXpress™ Solution," which refer to their proprietary technologies and approaches in pharmaceutical development and manufacturing. Recent employee healthcare news highlights Catalent's ongoing efforts to support employee well-being. For instance, their 2023 Corporate Responsibility Report details initiatives in employee health and wellness, such as investments in diverse and inclusive workplace practices and contributions to STEM education
New call-to-action

Additional Articles

Check Out Articles for Catalent employees

Loading...

For more information you can reach the plan administrator for Catalent at 14 Schoolhouse Road Somerset, NJ 8873; or by calling them at +1 908-809-1300.

https://www.thelayoff.com/catalent https://www.fiercepharma.com/pharma/catalent-unveils-recent-300-person-layoff-round-it-awaits-165b-novo-buyout https://bloomingtonian.com/2023/05/31/catalent-to-cut-another-150-positions-and-reorganize-in-bloomington-indiana/ https://indianapublicmedia.org/news/catalent-cutting-130-positions-at-bloomington-facility-this-week.php https://investor.catalent.com/financial-news/news-details/2024/Catalent-Inc.-Reports-Third-Quarter-Fiscal-2024-Results/default.aspx https://careers.catalent.com/us/en/benefits https://www.cashbalancedesign.com/resources/contribution-limits/ https://www.emparion.com/cash-balance-pension-plan-faq/ https://www.kiplinger.com/retirement/cash-balance-pension-plan-options https://www.futureplan.com/resources/news-articles/defined-benefit-cash-balance-plan-key-priorities/ https://investor.catalent.com/financial-news/news-details/2023/Catalent-Inc.-Reports-Preliminary-First-Quarter-Fiscal-2024-Results-and-Reaffirms-Full-Year-Fiscal-2024-Guidance/default.aspx https://careers.catalent.com/us/en/benefits https://www.fiercepharma.com/pharma/catalent-unveils-recent-300-person-layoff-round-it-awaits-165b-novo-buyout https://investor.catalent.com/ https://investor.catalent.com/financial-news/news-details/2023/Catalent-Inc.-Reports-Preliminary-Fourth-Quarter-and-Fiscal-2023-Results/default.aspx https://www.catalent.com/catalent-news/catalent-publishes-fourth-annual-corporate-responsibility-report/ https://annualreport.stocklight.com/nyse/ctlt/231007947.pdf https://creativeplanning.com/insights/financial-planning/how-to-use-the-net-unrealized-appreciation-nua-strategy-in-your-401k/ https://carlsoncap.com/articles/nua-net-unrealized-appreciation/ https://www.fidelity.com/learning-center/personal-finance/retirement/company-stock https://turbotax.intuit.com/tax-tips/retirement/net-unrealized-appreciation-nua-tax-treatment-amp-strategies/c71vBJZ2B https://investor.catalent.com/financial-news/news-details/2024/Novo-Holdings-to-Acquire-Catalent/default.aspx https://www.catalent.com/catalent-news/novo-holdings-to-acquire-catalent/ https://www.dcatvci.org/features/manufacturing-fallout-of-novos-16-5-billion-acquisition-of-catalent/ https://www.fiercepharma.com/pharma/catalent-unveils-recent-300-person-layoff-round-it-awaits-165b-novo-buyout https://www.thelayoff.com/t/1kgvERTs https://contracts.justia.com/ https://www.sec.gov/

*Please see disclaimer for more information

Relevant Articles

Check Out Articles for Catalent employees